Trials / Unknown
UnknownNCT05557253
Effects of Remimazolam on the Intraoperative Hemodynamics in Bypass Surgery
Effects of Remimazolam on the Intraoperative Hemodynamic Parameters in Patients Undergoing Extracranial-intracranial Bypass Surgery: a Prospective Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is a randomized, controlled trial. A total of 72 patients will be randomized to receive remimazolam anesthesia or balanced anesthesia (propofol + desflurane) during extracranial-intracranial bypass surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam | Anesthesia induction: remimazolam 6-12 mg/kg/h Anesthesia maintenance: remimazolam 1-2 mg/kg/h |
| DRUG | Balanced Anesthesia | Anesthesia induction: propofol 1.5-2 mg/kg Anesthesia maintenance: Desflurane 6-8 vol% |
Timeline
- Start date
- 2022-10-20
- Primary completion
- 2023-10-30
- Completion
- 2023-12-30
- First posted
- 2022-09-27
- Last updated
- 2022-10-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05557253. Inclusion in this directory is not an endorsement.